Get started
Author

Michael F. Mazurek

Observed names: M. F. Mazurek, MICHAEL F. MAZUREK, Mazurek, Michael F., Michael F Mazurek, Michael Mazurek
Observed institutions: Harvard University, Trillium Health Centre, McLean Hospital, McMaster University Medical Centre, McMaster Children's Hospital, Massachusetts General Hospital, Ohio University, Sendai City Hospital, St. Joseph’s Healthcare Hamilton, McMaster University
ORCID: 0009-0005-3902-4952
Observed ORCID: 0009-0005-3902-4952
OpenAlex ID: A5111623613
Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid
1986 · M. Flint Beal, Neil W. Kowall, et al. · Nature · 1,286
Catatonia: Our current understanding of its diagnosis, treatment and pathophysiology
2016 · Sean A Rasmussen, Michael F Mazurek, et al. · World Journal of Psychiatry · 334
PDF
Reduced Numbers of Somatostatin Receptors in the Cerebral Cortex in Alzheimer's Disease
1985 · M. Flint Beal, Michael F. Mazurek, et al. · Science · 251
Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease
1986 · M. Flint Beal, Michael F. Mazurek, et al. · Annals of Neurology · 160
The Psychiatric Manifestations of Mitochondrial Disorders
2012 · Rebecca E. Anglin, Sarah L. Garside, et al. · The Journal of Clinical Psychiatry · 149
A postmortem study of amino acid neurotransmitters in Alzheimer's disease
1986 · David W. Ellison, M. Flint Beal, et al. · Annals of Neurology · 139
The Treatment of Neuroleptic Malignant Syndrome are Dantrolene and Bromocriptine Useful Adjuncts to Supportive Care?
1991 · Patricia I. Rosebush, Thomas Stewart, et al. · The British Journal of Psychiatry · 126
The Neuropsychiatric Profile of Addison's Disease: Revisiting a Forgotten Phenomenon
2006 · R. E. Anglin, P. I. Rosebush, et al. · Journal of Neuropsychiatry · 121
Neurologic side effects in neuroleptic-naive patients treated with haloperidol or risperidone
1999 · Patricia I. Rosebush, Michael F. Mazurek · Neurology · 119
Widespread reduction of somatostatin‐like immunoreactivity in the cerebral cortex in Alzheimer's disease
1986 · M. Flint Beal, Michael F. Mazurek, et al. · Annals of Neurology · 103
Neuropsychiatric Aspects of the Adult Variant of Tay-Sachs Disease
1998 · Glenda M. MacQueen, Patricia I. Rosebush, et al. · Journal of Neuropsychiatry · 93
Catatonia After Benzodiazepine Withdrawal
1996 · Patricia I. Rosebush, Michael F. Mazurek · Journal of Clinical Psychopharmacology · 89
Catatonia in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition
2010 · Andrew Francis, Max Fink, et al. · Journal of Ect · 87
Substance P‐like immunoreactivity is reduced in Alzheimer's disease cerebral cortex
1987 · M. Flint Beal, Michael F. Mazurek · Neurology · 87
Somatostatin and neuropeptide Y concentrations in pathologically graded cases of huntington's disease
1988 · M. Flint Beal, Michael F. Mazurek, et al. · Annals of Neurology · 85
Behavioral Characterization of Quinolinate-Induced Lesions of the Medial Striatum: Relevance for Huntington's Disease
1996 · J.C.S. Furtado, Michael F. Mazurek · Experimental Neurology · 81
The Psychiatric Presentation of Mitochondrial Disorders in Adults
2012 · Rebecca E. Anglin, Mark A. Tarnopolsky, et al. · Journal of Neuropsychiatry · 77
The Neuropsychiatry of Adult-Onset Adrenoleukodystrophy
1999 · Patricia I. Rosebush, Sarah Garside, et al. · Journal of Neuropsychiatry · 73
Oxytocin in Alzheimer's disease
1987 · Michael F. Mazurek, M. Flint Beal, et al. · Neurology · 71
CSF somatostatin‐like immunoreactivity in dementia
1986 · M. Flint Beal, John H. Growdon, et al. · Neurology · 71
The mitochondrial genome and psychiatric illness
2012 · Rebecca E.S. Anglin, Michael F. Mazurek, et al. · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · 68
Vasopressin in Alzheimer's disease: A study of postmortem brain concentrations
1986 · Michael F. Mazurek, M. Flint Bed, et al. · Annals of Neurology · 59
Catatonia: Re-awakening to a forgotten disorder
1999 · Patricia I. Rosebush, Michael F. Mazurek · Movement Disorders · 56
A detailed examination of substance P in pathologically graded cases of Huntington's disease
1988 · M. Flint Beal, David W. Ellison, et al. · Journal of the Neurological Sciences · 54
The cortical lesion of Huntington's disease: Further neurochemical characterization, and reproduction of some of the histological and neurochemical features by N‐methyl‐ D ‐aspartate lesions of rat cortex
1992 · Elsdon Storey, Neil W. Kowall, et al. · Annals of Neurology · 53
Works count: 76
Citation count: 4,820
H-index: 35
I10-index: 53
Year
Topic
Type